Purpose: To examine whether overall survival (OS) differs for male and female patients with advanced soft-tissue sarcoma (STS).
Experimental Design: The study included patients from Kaiser Permanente Northern California and Stanford Cancer Center with grade 2 and 3 locally advanced or metastatic STS whose tumor underwent next-generation sequencing. We used Cox regression modeling to examine association of sex and OS adjusting for other important factors.